Amends TCA Title 4; Title 38, Chapter 3; Title 39, Chapter 17; Title 43; Title 50; Title 53; Title 63; Title 67 and Title 68.
This bill establishes a framework within which to authorize access to medical cannabis on a regulated basis for patients with qualifying medical conditions and that licenses and regulates the processes for cultivation, production, distribution, transport, selling, and acquiring cannabis for medical use and research. <br /> <br /> MEDICAL CANNABIS CARD - PATIENT and CAREGIVER<br /> <br /> This bill prohibits a person from acquiring, possessing, or using a medical cannabis product without a valid medical cannabis card issued pursuant to this bill. A medical cannabis card may only be issued to: qualified patient (defined as a resident of this state who is at least 18 years of age, has been diagnosed with a qualifying condition, and has met the requirements of this bill to obtain a card); or to a qualifying caregiver (a caregiver is defined as a resident of this state who is 18 years of age or older; meets the regulatory requirements under this bill); and has agreed to assist with the medical use of cannabis of another person with, or by applying for, a medical cannabis card.<br /> <br /> In order to qualify for and obtain a medical cannabis card from the commission, a patient must, among other things: complete and sign a written application form, subject to the penalties of perjury; pay an application fee of $65.00, or other amount as determined by the medical cannabis commission (created by this bill); and submit either: <br /> <br /> (1) A written document signed and dated by a healthcare provider confirming that the patient has been diagnosed with a qualifying condition; or <br /> (2) The patient's medical records from a healthcare provider confirming that the patient has been diagnosed with a qualifying medical condition. Such records must be reviewed and accepted by the commission as adequate proof that the patient requesting the card has been so diagnosed.<br /> <br /> This bill sets out in detail the requirements for a diagnosis of a qualifying condition by a healthcare provider. This bill also establishes the requirements for the issuance of a medical cannabis card to a parent or legal guardian of a minor for use by the minor. One such requirement is that the submission of proof that the parent or legal guardian has qualified as a caregiver.<br /> <br /> Under this bill, a qualified patient may designate a caregiver to assist with the purchase and use of medical cannabis. If a qualified patient is under 18 years of age, only a caregiver may purchase or administer cannabis to the qualified patient. When a qualified patient has a designated caregiver, only the designated caregiver is authorized to purchase cannabis; a patient with a designated caregiver is not authorized to purchase cannabis. In order to qualify for and obtain a medical cannabis card, a caregiver must, among other things: pay an application fee of $65.00, or other amount as determined by the commission; not have ownership interest in or contract or employment relationship with a licensed provider, dispensary, or testing facility; and identify each patient for whom the caregiver provides care, including a confirmation of the caregiver relationship in writing from each qualified patient. This bill limits a caregiver to providing care for no more than 10 qualified patients at any given time.<br /> <br /> A registered caregiver may lawfully acquire and possess cannabis, but not use cannabis without the caregiver actually being diagnosed with a qualifying medical condition and issued a medical cannabis card as a qualified patient. In order for a caregiver to act on behalf of a minor or adult patient to purchase, possess, and administer medical cannabis, the caregiver must obtain the caregiver medical cannabis card, and the patient must have a valid patient medical cannabis card, issued by the commission. A caregiver may receive compensation from the qualified patient or other entity for any services provided to the qualified patient.<br /> <br /> A medical cannabis card will be valid for two years. This bill establishes the renewal process for a card and requires the commission to promulgate appropriate rules regarding the application, issuance, and denial process for cards. This bill specifies that the rules may not prohibit the issuance or use of a medical cannabis card based on an arrest for any felony or misdemeanor unless the arrest is for a violation of this bill.<br /> <br /> This bill specifies that the state will recognize and give reciprocity to medical cannabis cards issued in other states, and that a cardholder from another state is allowed temporary access to dispensaries in this state under the conditions authorized by the commission by rule.<br /> <br /> PATIENT REGISTRY SYSTEM and TRACKING<br /> <br /> This bill requires the commission to create and utilize a patient registry system, by no later than July 31, 2020. The system will consist of, among other things, application forms and procedures for obtaining all patient and caregiver medical cannabis cards; and a system for tracking the application process and the cards that are issued. The department of agriculture and law enforcement will have access to the patient registry in order to avoid counterfeiting of cards, minimize illegal usage, and to attain maximum compliance with this bill. <br /> <br /> Under this bill, by no later than July 31, 2020, the commission must ensure that a process is available for healthcare providers to electronically report a qualifying diagnosis as part of the patient medical cannabis card registry process.<br /> <br /> This bill requires the commission to procure and utilize a secure, online system for patient registration and seed-to-sale tracking. All data related to the implementation of this bill, including, but not limited to, application forms, licensing information, registration of medical cannabis card holders and caregivers, compliance, and the status of cannabis research programs must be maintained in a secure system developed or procured by the commission. This bill requires the commission to provide annual written reports, with the first due no later than July 31, 2020, tracking implementation of this bill. <br /> <br /> MEDICAL CANNABIS COMMISSION<br /> <br /> This bill creates the Tennessee medical cannabis commission, to consist of nine members. By no later than August 30, 2019, the members are to be appointed by the governor, after receiving three appointment recommendations from the speaker of the senate, and three appointment recommendations from the speaker of the house. If recommendations from the speakers are not delivered to the governor by August 12, 2019, the governor may proceed on all nine appointments. This bill sets out the qualifications for being a commission member, and requires the governor to appoint:<br /> <br /> (1) One person with professional experience in industrial or agricultural systems management, including commodities, manufacturing, or distribution in a regulated industry;<br /> (2) One person with professional experience in legal or social justice issues related to a regulated industry; <br /> (3) One person with professional experience in public health, mental health, substance use, or toxicology, and<br /> (4) At least one person: experienced in multiple crop development and agricultural practices, as recommended by the speaker of the senate; and experienced in public or rural land use management, as recommended by the speaker of the house of representatives.<br /> <br /> This bill prohibits a person from both serving on the commission and being a registered lobbyist. If a registered lobbyist is appointed or otherwise named as a member of the commission, the person must terminate all employment and business association as a lobbyist. <br /> <br /> Commission members will serve four-year terms, but may be reappointed for one additional term at the pleasure of the governor. Each member of the commission will receive $700 for each meeting of the commission that the member attends and will be reimbursed for their actual and necessary expenses incurred in connection with their official duties. <br /> <br /> For administrative and rulemaking purposes and for the purpose of issuing fast tract licenses (discussed below), this bill requires the commission to hold a minimum of two regularly scheduled meetings each month in the first 12 months commencing no later than September 16, 2019. After that, this bill requires the commission to meet at least once each month in Nashville each month and to hold such other meetings as may be necessary for the commission to transact and perform its official duties and functions. The commission may hold a special meeting at any time it deems necessary and advisable in the performance of its official duties. <br /> <br /> This bill authorizes the commission to appoint a director and assistant director to serve at the pleasure of the commission. The commission will establish the directors salary, with the approval of the appropriate state officials as now required by law. The office of the director will be in Nashville. This bill sets out the qualifications for and duties of the director. The assistant director, if licensed to practice law in this state, may also be designated by the commission to serve as a hearing officer. The director and assistant director are to be reimbursed for travel expenses.<br /> <br /> This bill directs the commission to coordinate with the department of agriculture to appoint a chief inspection and enforcement officer who will serve under the commissioner of agriculture. This bill details the qualifications for the chief inspection and enforcement officer. Such officer will be reimbursed for travel expenses.<br /> <br /> The director, the chief inspection and enforcement officer, and all other inspection and enforcement personnel must be employed only on a full-time basis. This bill authorizes the commission to retain legal counsel familiar with requirements of this bill and medical cannabis licensing and best practices in other states.<br /> <br /> A violation of this bill's provisions governing prohibited conduct by commission members will be a Class C misdemeanor.<br /> <br /> LICENSING/FAST TRACK LICENSES<br /> <br /> This bill provides that provisional approval of fast track rural and urban licenses must be completed by April 1, 2020, and final approval or denial of the provisional fast track licenses must be completed by November 15, 2020. This bill requires the commission to promulgate rules that establish on-site inspection criteria applicable in the final approval or denial process for provisional fast track licenses. <br /> <br /> In order to facilitate an initial level of product availability and avoid a program delay dependent on rulemaking, this bill requires the commission to expeditiously review and issue approved provisional fast track licenses no later than April 1, 2020. By July 31, 2020, the commission must expeditiously review and commence approval of all medical cannabis card requests that meet the requirements of this bill. This bill further requires the commission to move expeditiously to promulgate rules by July 31, 2020. <br /> <br /> The cultivation, processing, transportation, manufacturing, packaging, dispensing, sale, and use of any form of medical cannabis is subject to licensing under this bill. This bill requires the commission to license all medical cannabis providers to ensure statewide patient access to pharmaceutical grade cannabis and to ensure compliance with this bill.<br /> <br /> This bill requires the commission to issue provisional licenses in advance of the July 31, 2020, rulemaking deadline. A provisional fast track license will not be finally approved or denied until after an onsite inspection of all facilities pursuant to rules promulgated by the commission. This bill sets out in detail the requirements governing provisional fast tract licenses, including the payment of an application fee of $85,000 for certain licenses, the categorizing of the licenses as urban omni licenses and rural vertically integrated (RUVI) licenses, and the limit on the number of such licenses that will be granted (See SECTION 13 of the bill). <br /> <br /> INSPECTION and ENFORCEMENT<br /> <br /> This bill requires the department to perform all statutory and regulatory inspection and enforcement requirements under this bill. This bill specifies that costs related to department staffing needs and implementation and enforcement of this bill are to be borne by the commission. This bill establishes the protocols for testing.<br /> <br /> PREEMPTION and LOCAL BAN <br /> <br /> This bill specifies that the state will preemptively regulate medical cannabis from seed to sale to use and reasonably regulate and control all aspects of industry to meet the stated intent of this bill. Any county or municipality seeking to ban the cultivation, processing, manufacture, or sale of medical cannabis within its jurisdiction may do so by a two-thirds vote of the local legislative body, if such occurs by July 31, 2020. <br /> <br /> TAXATION and MEDICAL CANNABIS FUND<br /> <br /> This bill:<br /> <br /> (1) Authorizes a county or municipality to tax the sale of medical cannabis at a rate not to exceed 2.1 percent;<br /> (2) Imposes a state tax of 9 percent on the sales price of medical cannabis when sold at retail in this state; and<br /> (3) Imposes an excise tax equal to 10 percent of the net earnings for the next preceding fiscal year for business done in this state during that fiscal year. This tax will not apply to RUVI licensees. <br /> <br /> This bill creates medical cannabis fund, in which will deposited moneys collected pursuant to this bill, includes fees, tax revenue, and any moneys appropriated to the fund by the general assembly for the initial operation of the commission. <br /> <br /> This bill specifies that tax collected from the retail sale of medical cannabis will be apportioned and allocated in the following manner:<br /> <br /> (1) 10 percent to the TBI for opioid and methamphetamine drug enforcement purposes;<br /> (2) 25 percent to the department of agriculture for programs and grants administered by the department that facilitate agricultural development in this state, including, but not limited to, the agriculture enterprise fund and the Tennessee agricultural enhancement program;<br /> (3) 20 percent to the department of economic and community development for community and rural development program grants administered by the department; and<br /> (4) 45 percent to the medical cannabis fund.<br /> <br /> Upon a determination by the general assembly that the commission has established sufficient revenues for the administration of this bill, the general assembly will direct the department of revenue to transfer any excess balance in the medical cannabis fund to the general fund to repay any appropriation made by the general assembly in the implementation of this bill.<br /> <br /> OTHER PROVISIONS<br /> <br /> This bill specifies that it does not:<br /> <br /> (1) Require an insurer to pay for or reimburse a person for costs associated with the medical use of cannabis;<br /> (2) Require any employer to allow the medical use of cannabis in the workplace or to modify the job or working conditions of a person who engages in the medical use of cannabis that are based upon the reasonable business purposes of the employer; or<br /> (3) Limit the ability of an employer to establish, continue, or enforce a drug-free workplace program or policy.<br /> <br /> QUALIFYING CONDITIONS<br /> <br /> The following are qualifying conditions for purposes of the medical use of cannabis under this bill: cancer; glaucoma; epilepsy; HIV/AIDS; Crohn's disease; muscular sclerosis; opioid addiction; renal failure; severe nausea or chronic pain; any medical condition producing cachexia, persistent muscle spasm, or seizures; post traumatic stress syndrome; chronic radiculopathy; severe psoriasis; post-laminectomy syndrome; psoriatic arthritis; complex pain syndrome, including trigeminal neuralgia, amyotrophic lateral sclerosis (ALS), and Parkinson's disease; end-of-life pain management or palliative care; terminal conditions; and the following conditions if the patient is younger than 18 years of age: cerebral palsy, cystic fibrosis; osteogenesis imperfecta; and muscular dystrophy. This bill provides that the commission may, by rule, add other qualifying conditions.<br /> <br />
This bill establishes a framework within which to authorize access to medical cannabis on a regulated basis for patients with qualifying medical conditions and that licenses and regulates the processes for cultivation, production, distribution, transport, selling, and acquiring cannabis for medical use and research. <br /> <br /> MEDICAL CANNABIS CARD - PATIENT and CAREGIVER<br /> <br /> This bill prohibits a person from acquiring, possessing, or using a medical cannabis product without a valid medical cannabis card issued pursuant to this bill. A medical cannabis card may only be issued to: qualified patient (defined as a resident of this state who is at least 18 years of age, has been diagnosed with a qualifying condition, and has met the requirements of this bill to obtain a card); or to a qualifying caregiver (a caregiver is defined as a resident of this state who is 18 years of age or older; meets the regulatory requirements under this bill); and has agreed to assist with the medical use of cannabis of another person with, or by applying for, a medical cannabis card.<br /> <br /> In order to qualify for and obtain a medical cannabis card from the commission, a patient must, among other things: complete and sign a written application form, subject to the penalties of perjury; pay an application fee of $65.00, or other amount as determined by the medical cannabis commission (created by this bill); and submit either: <br /> <br /> (1) A written document signed and dated by a healthcare provider confirming that the patient has been diagnosed with a qualifying condition; or <br /> (2) The patient's medical records from a healthcare provider confirming that the patient has been diagnosed with a qualifying medical condition. Such records must be reviewed and accepted by the commission as adequate proof that the patient requesting the card has been so diagnosed.<br /> <br /> This bill sets out in detail the requirements for a diagnosis of a qualifying condition by a healthcare provider. This bill also establishes the requirements for the issuance of a medical cannabis card to a parent or legal guardian of a minor for use by the minor. One such requirement is that the submission of proof that the parent or legal guardian has qualified as a caregiver.<br /> <br /> Under this bill, a qualified patient may designate a caregiver to assist with the purchase and use of medical cannabis. If a qualified patient is under 18 years of age, only a caregiver may purchase or administer cannabis to the qualified patient. When a qualified patient has a designated caregiver, only the designated caregiver is authorized to purchase cannabis; a patient with a designated caregiver is not authorized to purchase cannabis. In order to qualify for and obtain a medical cannabis card, a caregiver must, among other things: pay an application fee of $65.00, or other amount as determined by the commission; not have ownership interest in or contract or employment relationship with a licensed provider, dispensary, or testing facility; and identify each patient for whom the caregiver provides care, including a confirmation of the caregiver relationship in writing from each qualified patient. This bill limits a caregiver to providing care for no more than 10 qualified patients at any given time.<br /> <br /> A registered caregiver may lawfully acquire and possess cannabis, but not use cannabis without the caregiver actually being diagnosed with a qualifying medical condition and issued a medical cannabis card as a qualified patient. In order for a caregiver to act on behalf of a minor or adult patient to purchase, possess, and administer medical cannabis, the caregiver must obtain the caregiver medical cannabis card, and the patient must have a valid patient medical cannabis card, issued by the commission. A caregiver may receive compensation from the qualified patient or other entity for any services provided to the qualified patient.<br /> <br /> A medical cannabis card will be valid for two years. This bill establishes the renewal process for a card and requires the commission to promulgate appropriate rules regarding the application, issuance, and denial process for cards. This bill specifies that the rules may not prohibit the issuance or use of a medical cannabis card based on an arrest for any felony or misdemeanor unless the arrest is for a violation of this bill.<br /> <br /> This bill specifies that the state will recognize and give reciprocity to medical cannabis cards issued in other states, and that a cardholder from another state is allowed temporary access to dispensaries in this state under the conditions authorized by the commission by rule.<br /> <br /> PATIENT REGISTRY SYSTEM and TRACKING<br /> <br /> This bill requires the commission to create and utilize a patient registry system, by no later than July 31, 2020. The system will consist of, among other things, application forms and procedures for obtaining all patient and caregiver medical cannabis cards; and a system for tracking the application process and the cards that are issued. The department of agriculture and law enforcement will have access to the patient registry in order to avoid counterfeiting of cards, minimize illegal usage, and to attain maximum compliance with this bill. <br /> <br /> Under this bill, by no later than July 31, 2020, the commission must ensure that a process is available for healthcare providers to electronically report a qualifying diagnosis as part of the patient medical cannabis card registry process.<br /> <br /> This bill requires the commission to procure and utilize a secure, online system for patient registration and seed-to-sale tracking. All data related to the implementation of this bill, including, but not limited to, application forms, licensing information, registration of medical cannabis card holders and caregivers, compliance, and the status of cannabis research programs must be maintained in a secure system developed or procured by the commission. This bill requires the commission to provide annual written reports, with the first due no later than July 31, 2020, tracking implementation of this bill. <br /> <br /> MEDICAL CANNABIS COMMISSION<br /> <br /> This bill creates the Tennessee medical cannabis commission, to consist of nine members. By no later than August 30, 2019, the members are to be appointed by the governor, after receiving three appointment recommendations from the speaker of the senate, and three appointment recommendations from the speaker of the house. If recommendations from the speakers are not delivered to the governor by August 12, 2019, the governor may proceed on all nine appointments. This bill sets out the qualifications for being a commission member, and requires the governor to appoint:<br /> <br /> (1) One person with professional experience in industrial or agricultural systems management, including commodities, manufacturing, or distribution in a regulated industry;<br /> (2) One person with professional experience in legal or social justice issues related to a regulated industry; <br /> (3) One person with professional experience in public health, mental health, substance use, or toxicology, and<br /> (4) At least one person: experienced in multiple crop development and agricultural practices, as recommended by the speaker of the senate; and experienced in public or rural land use management, as recommended by the speaker of the house of representatives.<br /> <br /> This bill prohibits a person from both serving on the commission and being a registered lobbyist. If a registered lobbyist is appointed or otherwise named as a member of the commission, the person must terminate all employment and business association as a lobbyist. <br /> <br /> Commission members will serve four-year terms, but may be reappointed for one additional term at the pleasure of the governor. Each member of the commission will receive $700 for each meeting of the commission that the member attends and will be reimbursed for their actual and necessary expenses incurred in connection with their official duties. <br /> <br /> For administrative and rulemaking purposes and for the purpose of issuing fast tract licenses (discussed below), this bill requires the commission to hold a minimum of two regularly scheduled meetings each month in the first 12 months commencing no later than September 16, 2019. After that, this bill requires the commission to meet at least once each month in Nashville each month and to hold such other meetings as may be necessary for the commission to transact and perform its official duties and functions. The commission may hold a special meeting at any time it deems necessary and advisable in the performance of its official duties. <br /> <br /> This bill authorizes the commission to appoint a director and assistant director to serve at the pleasure of the commission. The commission will establish the directors salary, with the approval of the appropriate state officials as now required by law. The office of the director will be in Nashville. This bill sets out the qualifications for and duties of the director. The assistant director, if licensed to practice law in this state, may also be designated by the commission to serve as a hearing officer. The director and assistant director are to be reimbursed for travel expenses.<br /> <br /> This bill directs the commission to coordinate with the department of agriculture to appoint a chief inspection and enforcement officer who will serve under the commissioner of agriculture. This bill details the qualifications for the chief inspection and enforcement officer. Such officer will be reimbursed for travel expenses.<br /> <br /> The director, the chief inspection and enforcement officer, and all other inspection and enforcement personnel must be employed only on a full-time basis. This bill authorizes the commission to retain legal counsel familiar with requirements of this bill and medical cannabis licensing and best practices in other states.<br /> <br /> A violation of this bill's provisions governing prohibited conduct by commission members will be a Class C misdemeanor.<br /> <br /> LICENSING/FAST TRACK LICENSES<br /> <br /> This bill provides that provisional approval of fast track rural and urban licenses must be completed by April 1, 2020, and final approval or denial of the provisional fast track licenses must be completed by November 15, 2020. This bill requires the commission to promulgate rules that establish on-site inspection criteria applicable in the final approval or denial process for provisional fast track licenses. <br /> <br /> In order to facilitate an initial level of product availability and avoid a program delay dependent on rulemaking, this bill requires the commission to expeditiously review and issue approved provisional fast track licenses no later than April 1, 2020. By July 31, 2020, the commission must expeditiously review and commence approval of all medical cannabis card requests that meet the requirements of this bill. This bill further requires the commission to move expeditiously to promulgate rules by July 31, 2020. <br /> <br /> The cultivation, processing, transportation, manufacturing, packaging, dispensing, sale, and use of any form of medical cannabis is subject to licensing under this bill. This bill requires the commission to license all medical cannabis providers to ensure statewide patient access to pharmaceutical grade cannabis and to ensure compliance with this bill.<br /> <br /> This bill requires the commission to issue provisional licenses in advance of the July 31, 2020, rulemaking deadline. A provisional fast track license will not be finally approved or denied until after an onsite inspection of all facilities pursuant to rules promulgated by the commission. This bill sets out in detail the requirements governing provisional fast tract licenses, including the payment of an application fee of $85,000 for certain licenses, the categorizing of the licenses as urban omni licenses and rural vertically integrated (RUVI) licenses, and the limit on the number of such licenses that will be granted (See SECTION 13 of the bill). <br /> <br /> INSPECTION and ENFORCEMENT<br /> <br /> This bill requires the department to perform all statutory and regulatory inspection and enforcement requirements under this bill. This bill specifies that costs related to department staffing needs and implementation and enforcement of this bill are to be borne by the commission. This bill establishes the protocols for testing.<br /> <br /> PREEMPTION and LOCAL BAN <br /> <br /> This bill specifies that the state will preemptively regulate medical cannabis from seed to sale to use and reasonably regulate and control all aspects of industry to meet the stated intent of this bill. Any county or municipality seeking to ban the cultivation, processing, manufacture, or sale of medical cannabis within its jurisdiction may do so by a two-thirds vote of the local legislative body, if such occurs by July 31, 2020. <br /> <br /> TAXATION and MEDICAL CANNABIS FUND<br /> <br /> This bill:<br /> <br /> (1) Authorizes a county or municipality to tax the sale of medical cannabis at a rate not to exceed 2.1 percent;<br /> (2) Imposes a state tax of 9 percent on the sales price of medical cannabis when sold at retail in this state; and<br /> (3) Imposes an excise tax equal to 10 percent of the net earnings for the next preceding fiscal year for business done in this state during that fiscal year. This tax will not apply to RUVI licensees. <br /> <br /> This bill creates medical cannabis fund, in which will deposited moneys collected pursuant to this bill, includes fees, tax revenue, and any moneys appropriated to the fund by the general assembly for the initial operation of the commission. <br /> <br /> This bill specifies that tax collected from the retail sale of medical cannabis will be apportioned and allocated in the following manner:<br /> <br /> (1) 10 percent to the TBI for opioid and methamphetamine drug enforcement purposes;<br /> (2) 25 percent to the department of agriculture for programs and grants administered by the department that facilitate agricultural development in this state, including, but not limited to, the agriculture enterprise fund and the Tennessee agricultural enhancement program;<br /> (3) 20 percent to the department of economic and community development for community and rural development program grants administered by the department; and<br /> (4) 45 percent to the medical cannabis fund.<br /> <br /> Upon a determination by the general assembly that the commission has established sufficient revenues for the administration of this bill, the general assembly will direct the department of revenue to transfer any excess balance in the medical cannabis fund to the general fund to repay any appropriation made by the general assembly in the implementation of this bill.<br /> <br /> OTHER PROVISIONS<br /> <br /> This bill specifies that it does not:<br /> <br /> (1) Require an insurer to pay for or reimburse a person for costs associated with the medical use of cannabis;<br /> (2) Require any employer to allow the medical use of cannabis in the workplace or to modify the job or working conditions of a person who engages in the medical use of cannabis that are based upon the reasonable business purposes of the employer; or<br /> (3) Limit the ability of an employer to establish, continue, or enforce a drug-free workplace program or policy.<br /> <br /> QUALIFYING CONDITIONS<br /> <br /> The following are qualifying conditions for purposes of the medical use of cannabis under this bill: cancer; glaucoma; epilepsy; HIV/AIDS; Crohn's disease; muscular sclerosis; opioid addiction; renal failure; severe nausea or chronic pain; any medical condition producing cachexia, persistent muscle spasm, or seizures; post traumatic stress syndrome; chronic radiculopathy; severe psoriasis; post-laminectomy syndrome; psoriatic arthritis; complex pain syndrome, including trigeminal neuralgia, amyotrophic lateral sclerosis (ALS), and Parkinson's disease; end-of-life pain management or palliative care; terminal conditions; and the following conditions if the patient is younger than 18 years of age: cerebral palsy, cystic fibrosis; osteogenesis imperfecta; and muscular dystrophy. This bill provides that the commission may, by rule, add other qualifying conditions.<br /> <br />
Track Tennessee Legislation Like a Pro
Join hundreds of professionals using LegisGo to stay ahead of legislative changes.
Instant Alerts
Get notified when bills you track move through the legislature
AI Summaries
Understand complex legislation in seconds with AI-powered analysis
Full Access
All 132 legislators, committee schedules, and voting records